-
A Fresh Look at Neurodegeneration
Alzheimer’s disease, Parkinson’s disease and other neurodegenerative conditions are typically seen – and treated – as distinct diseases with their own unique etiologies and targeted therapies. But a paper published recently in Translational Neurodegeneration outlines a new perspective, one that sees Alzheimer’s (AD), Parkinson’s (PD), amyotrophic lateral sclerosis (ALS), and Huntington’s disease (HD) as different…
-
Urolithin A & Neurodegeneration
The journal Alzheimer’s & Dementia recently published results suggesting that urolithin A may have potential benefit for reducing degeneration as a consequence of Alzheimer’s disease (AD) through multiple mechanisms, at least in an animal model. This adds to a growing body of evidence that urolithin A has a critically important role in supporting mitochondrial function,…
-
Do You Have Leaky Brain?
The NIH estimates that 20% of Americans have a diagnosable mental disorder, at a cost of $201 billion per year. The most common maladies are depression and phobias. In 2019, suicide was the 10th leading cause of death in the US, accounting for over 47,000 deaths overall. We are beginning to look at systemic inflammation and its…
-
Do You Have Leaky Brain?
The NIH estimates that 20% of Americans have a diagnosable mental disorder, at a cost of $201 billion per year. The most common maladies are depression and phobias. In 2014, the CDC issued a report indicating that the U.S. suicide rate reached 13 per 100,000, the highest it had been since 1986. We are beginning…